San Diego-based mostly Viking Therapeutics marked alone as a significant competitor in the weight loss drug sector in February right after revealing promising details from the mid-phase demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when offered to be a weekly injection As well as in March the